Thank you for attending THSNA 2026. The virtual meeting is now closed.
Use this page to browse all contributing authors.
Presentations for Sweta Gupta
Sex and age-based evaluation of a newly formulated intranasal DDAVP compared with intranasal DDAVP and subcutaneous DDAVP in type 1 von Willebrand disease |
Emicizumab for Severe von Willebrand Disease (VWD): the EmiVWD Study Enrollment 2026 |